List of Tables
Table 1. Catheter-Associated Bloodstream Infection Treatment Market Trends
Table 2. Catheter-Associated Bloodstream Infection Treatment Market Drivers & Opportunity
Table 3. Catheter-Associated Bloodstream Infection Treatment Market Challenges
Table 4. Catheter-Associated Bloodstream Infection Treatment Market Restraints
Table 5. Global Catheter-Associated Bloodstream Infection Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Catheter-Associated Bloodstream Infection Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Catheter-Associated Bloodstream Infection Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Catheter-Associated Bloodstream Infection Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Catheter-Associated Bloodstream Infection Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Catheter-Associated Bloodstream Infection Treatment
Table 13. Global Catheter-Associated Bloodstream Infection Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Catheter-Associated Bloodstream Infection Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Catheter-Associated Bloodstream Infection Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Catheter-Associated Bloodstream Infection Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Catheter-Associated Bloodstream Infection Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Catheter-Associated Bloodstream Infection Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Catheter-Associated Bloodstream Infection Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Catheter-Associated Bloodstream Infection Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. AstraZeneca Company Information
Table 58. AstraZeneca Introduction and Business Overview
Table 59. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AstraZeneca Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 61. AstraZeneca Recent Development
Table 62. CorMedix, Inc. Company Information
Table 63. CorMedix, Inc. Introduction and Business Overview
Table 64. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. CorMedix, Inc. Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 66. CorMedix, Inc. Recent Development
Table 67. Citus Pharmaceuticals Company Information
Table 68. Citus Pharmaceuticals Introduction and Business Overview
Table 69. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Citus Pharmaceuticals Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 71. Citus Pharmaceuticals Recent Development
Table 72. Fresenius Medical Care Company Information
Table 73. Fresenius Medical Care Introduction and Business Overview
Table 74. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Fresenius Medical Care Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 76. Fresenius Medical Care Recent Development
Table 77. Glenmark Pharmaceuticals Ltd. Company Information
Table 78. Glenmark Pharmaceuticals Ltd. Introduction and Business Overview
Table 79. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Glenmark Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 81. Glenmark Pharmaceuticals Ltd. Recent Development
Table 82. Geistlich Pharma Company Information
Table 83. Geistlich Pharma Introduction and Business Overview
Table 84. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Geistlich Pharma Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 86. Geistlich Pharma Recent Development
Table 87. Merck & Co., Inc. Company Information
Table 88. Merck & Co., Inc. Introduction and Business Overview
Table 89. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Merck & Co., Inc. Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 91. Merck & Co., Inc. Recent Development
Table 92. Pfizer Company Information
Table 93. Pfizer Introduction and Business Overview
Table 94. Pfizer Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Pfizer Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 96. Pfizer Recent Development
Table 97. TauroPhar GmbH Company Information
Table 98. TauroPhar GmbH Introduction and Business Overview
Table 99. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. TauroPhar GmbH Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 101. TauroPhar GmbH Recent Development
Table 102. Xellia Pharmaceuticals Ltd. Company Information
Table 103. Xellia Pharmaceuticals Ltd. Introduction and Business Overview
Table 104. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Xellia Pharmaceuticals Ltd. Catheter-Associated Bloodstream Infection Treatment Product Offerings
Table 106. Xellia Pharmaceuticals Ltd. Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Catheter-Associated Bloodstream Infection Treatment Downstream Customers
Table 110. Catheter-Associated Bloodstream Infection Treatment Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Catheter-Associated Bloodstream Infection Treatment Product Picture
Figure 2. Global Catheter-Associated Bloodstream Infection Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Catheter-Associated Bloodstream Infection Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Catheter-Associated Bloodstream Infection Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Catheter-Associated Bloodstream Infection Treatment Report Years Considered
Figure 7. Global Catheter-Associated Bloodstream Infection Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Catheter-Associated Bloodstream Infection Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Catheter-Associated Bloodstream Infection Treatment Revenue in 2023
Figure 10. Catheter-Associated Bloodstream Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Antibacterial Agents Picture
Figure 12. Antibiotic Picture
Figure 13. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Catheter-Associated Bloodstream Infection Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Catheter-Associated Bloodstream Infection Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital
Figure 19. Product Picture of Specialist Clinic
Figure 20. Product Picture of Other
Figure 21. Global Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Catheter-Associated Bloodstream Infection Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Catheter-Associated Bloodstream Infection Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Catheter-Associated Bloodstream Infection Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Catheter-Associated Bloodstream Infection Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Catheter-Associated Bloodstream Infection Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Catheter-Associated Bloodstream Infection Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Catheter-Associated Bloodstream Infection Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Catheter-Associated Bloodstream Infection Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Catheter-Associated Bloodstream Infection Treatment Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Catheter-Associated Bloodstream Infection Treatment Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Catheter-Associated Bloodstream Infection Treatment Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Catheter-Associated Bloodstream Infection Treatment Sales Volume (%), (2019-2030)
Figure 38. United States Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. China Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. China Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 56. India Catheter-Associated Bloodstream Infection Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Catheter-Associated Bloodstream Infection Treatment Sales Value by Type (%), 2023 VS 2030
Figure 58. India Catheter-Associated Bloodstream Infection Treatment Sales Value by Application (%), 2023 VS 2030
Figure 59. Catheter-Associated Bloodstream Infection Treatment Industrial Chain
Figure 60. Catheter-Associated Bloodstream Infection Treatment Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
